A Comparative Study of 50-Millesimal Potencies and Centesimal Potencies in the Treatment of Tinea Corporis: An Open, Randomised, Pilot Trial

Abstract

Introduction Standard management of dermatophytosis involves the use of topical antifungals in limited disease and oral therapy for more extensive cases. Despite the evidences favouring homeopathy in tinea corporis (TC) is inadequate, patients are increasingly opting for it. This trial attempts to assess the feasibility of a trial evaluating individualised homeopathic (IH) medicines in centesimal and 50-millesimal potencies in treating TC.

Methods An open, randomised, pilot feasibility trial was conducted at the dermatology outpatient of D. N. De Homoeopathic Medical College and Hospital, West Bengal, India. Patients were randomised to receive IH medicines in either centesimal potencies (n = 30) or in 50-millesimal potencies (n = 30). Primary outcome measure was intensity of pruritus on a 0 to 10 numeric rating scale; secondary outcomes were Skindex-29 and dermatology life quality index questionnaires—all measured at baseline, and after 6 and 12 weeks of intervention. Group differences were calculated on intention-to-treat (ITT) sample as well as following per protocol (PP) analysis.

Results Recruitment and attrition rates were 69 and 16.7% respectively. Both ITT and PP analysis revealed that intra-group changes in both the primary and secondary outcomes to be statistically significant in both the groups (all p < 0.05, one-way repeated measure analysis of variance). There were no significant group differences over 6 and 12 weeks (all p > 0.05, unpaired t-tests); thus, indicating similar pattern of improvement in both the groups. Most frequently used medicines were Natrum sulphuricum (28.3%), Natrum muriaticum (25%), Sulphur (8.3%) and Bacillinum (6.7%). No harms, unintended effects, homeopathic aggravations or any serious adverse events were reported from either group.

Conclusion An adequately powered trial exploring effectiveness of both scales in TC appeared to be feasible in future. Though the sample size was too small to arrive at any definite conclusion, both centesimal and 50-millesimal potencies of IH medicines appeared to be equally useful in improving pruritus intensity and quality of life in patients suffering from TC.

Keywords

centesimal potency - 50-millesimal potency - homeopathy - pilot trial - randomised controlled trials - tinea corporis

Author Contribution

PH, SKM and SG were involved in concept, literature search, clinical study, data acquisition, data interpretation and preparation of the article; ASR and SD were involved in clinical study and data acquisition; SS, MK and S. Saha were involved in design, data interpretation, statistical analysis and preparation of the article. All the authors reviewed and approved the final article.

Publication History

Article published online:
31 December 2021

• References

• 1 James WD, Elston D, Berger T. et al. Andrews' Diseases of the Skin Clinical Dermatology. 12th edition. London: Saunders/Elsevier; 2016: 285
• 2 Manson P, Farrar J. Manson's Tropical Diseases. 23rd edition. St. Louis: Elsevier Saunders; 2014: 445
• 3 Das S, De A, Saha R. et al. The current Indian epidemic of dermatophytosis: A study on causative agents and sensitivity patterns. Indian J Dermatol 2020; 65 (02) 118-122
• 4 Das K, Basak S, Ray S. A study on superficial fungal infection from West Bengal: A brief report. J Life Sci 2009; 1: 51-55
• 5 Kelly BP. Superficial fungal infections. Pediatr Rev 2012; 33 (04) e22-e37
• 6 Ely JW, Rosenfeld S, Seabury Stone M. Diagnosis and management of tinea infections. Am Fam Physician 2014; 90 (10) 702-710
• 7 Singh S, Verma P, Chandra U, Tiwary NK. Risk factors for chronic and chronic-relapsing tinea corporis, tinea cruris and tinea faciei: results of a case-control study. Indian J Dermatol Venereol Leprol 2019; 85 (02) 197-200
• 8 van Zuuren EJ, Fedorowicz Z, El-Gohary M. Evidence-based topical treatments for tinea cruris and tinea corporis: a summary of a Cochrane systematic review. Br J Dermatol 2015; 172 (03) 616-641
• 9 Sahoo AK, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: a comprehensive review. Indian Dermatol Online J 2016; 7 (02) 77-86
• 10 Simonart T, Kabagabo C, De Maertelaer V. Homoeopathic remedies in dermatology: a systematic review of controlled clinical trials. Br J Dermatol 2011; 165 (04) 897-905
• 11 Bhardwaj O, Manchanda R, Gupta R. Evaluation of bacillinum in tinea infection. Brit Hom J 1990; 79: 10-11
• 12 Hahnemann S. Organon of Medicine. In: Translated by Dudgeon R, Boericke W. (5th & 6th edition). New Delhi: B. Jain Publisher; 1982: 135-136
• 13 ICD-10-CM Diagnosis Code B35. 4: Tinea corporis. Accessed March 9, 2020 from: https://www.icd10data.com/ICD10CM/Codes/A00-B99/B35-B49/B35-/B35.4
• 14 Reich A, Chatzigeorkidis E, Zeidler C. et al. Tailoring the cut-off values of the visual analogue scale and numeric rating scale in itch assessment. Acta Derm Venereol 2017; 97 (06) 759-760
• 15 Chren MM. Skindex (Skindex, Skindex-29, Skindex-16). Accessed Oct 30, 2020 from: https://eprovide.mapi-trust.org/instruments/skindex
• 16 Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY. The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008; 159 (05) 997-1035
• 17 Schulz KF, Altman DG, Moher D. CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332
• 18 Dean ME, Coulter MK, Fisher P, Jobst K, Walach H. Reporting data on homeopathic treatments (RedHot): a supplement to CONSORT. Homeopathy 2007; 96 (01) 42-45
• 19 Dixit AK, Giri N. Tinea corporis: an evidence-based case report treated with homoeopathic medicine sepia. Homœopathic Links 2020; 33: 33-40
• 20 Bala R, Srivastava A. Constitutional treatment of tinea cruris in homoeopathy – a case report. Int J Health Sci Res 2019; 9: 54-61
• 21 Uttamchandani PA, Patil AD. Homoeopathy an alternative therapy for dermatophyte infections. Int J Health Sci Res 2019; 9: 316-320
• 22 Teste A. A Homoeopathic Treatise on the Diseases of Children. 6th edition. New Delhi: B. Jain Publishers Pvt. Ltd.; 1854: 192-205
• 23 Burnett JC. Vaccinosis and Its Cure by Thuja; with remarks on homoeoprophylaxis. New Delhi: B. Jain Publishers Pvt. Ltd; 1994: 90-92
• 24 Douglass ME. Skin Diseases their Description, Etiology, Diagnosis and Treatment According to the Law of Similars. New Delhi: Indian Books and Periodical Syndicate; 1900: 410-412